MDS Podcast

In this Hot Topic episode, Dr. Sarah Camargos talks with Prof. Janis Miyasaki about the meaning and benefits of palliative care and how it improves quality of care in movement disorders.

In this episode, Prof. Fanny Mochel discusses the rationale and key findings from a retrospective cohort study of patients with CSF1R-related disorder treated with hematopoietic stem cell transplantation, highlighting the potential of this therapy to achieve both clinical and radiological disease stabilization. Journal CME is available until September 24, 2026 Read the article.

In this episode, Dr. Divyani Garg converses with Prof. Kristina Simonyan on applying the standard alcohol challenge test, in combination with targeted genetic analysis in the GABAergic synapse pathways, in persons with laryngeal dystonia. Together they explore alcohol’s role in laryngeal dystonia, the genetic signatures that may predict responsiveness, and what this could mean for the future of treatment of laryngeal dystonia specifically, but also dystonia in general. Read the article.

Dr. Michele Matarazzo interviews Dr. Victor Hvingelby, the recipient of this year’s MDJ Research Article of the Year award. Together they discuss the use of PET tracers to assess microglial activation in isolated REM sleep behavior disorder and how these tools can better define prodromal Parkinson’s disease.

Dr. Sarah Camargos interviews Dr. Guillaume Cogan and Prof. Alexis Brice, the corresponding authors of the article selected as the Movement Disorders Review of the Year. Listen as their conversation dives into the new sequencing technologies, and the broader diagnosis they bring to the field.

Prof. Paul Wilmes breaks down his #mdscongress talk discussing the recent studies on the influences of the gut microbiome on PD. He also dives into future goals and what interventions may be beneficial for PD.

Prof. Susanne Schneider discusses all things dystonia. Listen as she reviews the revised MDS definition and classification system for dystonia, updates for neurodegeneration with brain iron accumulation, and the exciting future of genetic therapies.

Prof. Alessandra Fanciulli discusses how the MDS criteria for the diagnosis of MSA has made an impact on the field, the status of biomarker research, and optimal targets for disease-modifying trials for MSA.

Functional movement disorders (FMDs) are the most common subgroup of functional neurological disorders. Prof. Selma Aybek breaks down current trends for FMDs, controversies, and treatment preferences, including implementing an interdisciplinary team.

Developments in neuroimaging have grown a lot over the years. Dr. Thilo van Eimeren discusses biomarker development, both in tau and alpha synuclein, current research, and his hope for future successes.